| Michael Patrick Murphy, MD | |
|
2623 Shadelands Dr Ste 1, Walnut Creek, CA 94598-2512 | |
| (925) 933-8462 | |
| Not Available |
| Full Name | Michael Patrick Murphy |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 30 Years |
| Location | 2623 Shadelands Dr Ste 1, Walnut Creek, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013964410 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RS0012X | Internal Medicine - Sleep Medicine | A79494 (California) | Secondary |
| 207Y00000X | Otolaryngology | A79494 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stanford Health Care - Valleycare | Pleasanton, CA | Hospital |
| John Muir Medical Center - Walnut Creek Campus | Walnut creek, CA | Hospital |
| Stanford Health Care | Stanford, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Healthcare Alliance | 6305748799 | 346 |
News Archive
A new study published in the Journal of Biological Chemistry has revealed that drug Remdesivir could be useful in treating the deadly COVID-19 or the novel coronavirus that is infecting tens of thousands of people across the world.
Scientists have confirmed that prions, the mysterious proteins thought to cause chronic wasting disease (CWD) in deer, latch on tightly to certain minerals in soil and remain infectious.
With diabetes affecting the lives of millions of people throughout the Midwest, Meijer announced plans today to begin offering Metformin Immediate Release, the most commonly prescribed treatment for type 2 diabetes, at no cost to those with a medical prescription. Meijer's program will include doses prescribed in 500mg, 850mg and 1000mg tablets.
USHIFU, LLC (US HIFU), a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies and manufacturer of the Sonablate® 500 (Sonablate) medical device, announces the acquisition of certain Misonix HIFU assets and European distribution rights. In addition, through its transaction with Misonix, US HIFU acquires the Sonatherm® 600 medical device, a laparoscopic HIFU system used to ablate certain soft tissues.
› Verified 2 days ago
| Entity Name | Stanford Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437292927 PECOS PAC ID: 6709797491 Enrollment ID: O20031124000348 |
News Archive
A new study published in the Journal of Biological Chemistry has revealed that drug Remdesivir could be useful in treating the deadly COVID-19 or the novel coronavirus that is infecting tens of thousands of people across the world.
Scientists have confirmed that prions, the mysterious proteins thought to cause chronic wasting disease (CWD) in deer, latch on tightly to certain minerals in soil and remain infectious.
With diabetes affecting the lives of millions of people throughout the Midwest, Meijer announced plans today to begin offering Metformin Immediate Release, the most commonly prescribed treatment for type 2 diabetes, at no cost to those with a medical prescription. Meijer's program will include doses prescribed in 500mg, 850mg and 1000mg tablets.
USHIFU, LLC (US HIFU), a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies and manufacturer of the Sonablate® 500 (Sonablate) medical device, announces the acquisition of certain Misonix HIFU assets and European distribution rights. In addition, through its transaction with Misonix, US HIFU acquires the Sonatherm® 600 medical device, a laparoscopic HIFU system used to ablate certain soft tissues.
› Verified 2 days ago
| Entity Name | University Healthcare Alliance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760531198 PECOS PAC ID: 6305748799 Enrollment ID: O20040126000292 |
News Archive
A new study published in the Journal of Biological Chemistry has revealed that drug Remdesivir could be useful in treating the deadly COVID-19 or the novel coronavirus that is infecting tens of thousands of people across the world.
Scientists have confirmed that prions, the mysterious proteins thought to cause chronic wasting disease (CWD) in deer, latch on tightly to certain minerals in soil and remain infectious.
With diabetes affecting the lives of millions of people throughout the Midwest, Meijer announced plans today to begin offering Metformin Immediate Release, the most commonly prescribed treatment for type 2 diabetes, at no cost to those with a medical prescription. Meijer's program will include doses prescribed in 500mg, 850mg and 1000mg tablets.
USHIFU, LLC (US HIFU), a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies and manufacturer of the Sonablate® 500 (Sonablate) medical device, announces the acquisition of certain Misonix HIFU assets and European distribution rights. In addition, through its transaction with Misonix, US HIFU acquires the Sonatherm® 600 medical device, a laparoscopic HIFU system used to ablate certain soft tissues.
› Verified 2 days ago
| Entity Name | Lpch Medical Group Div Of Lucile |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417907940 PECOS PAC ID: 0840298543 Enrollment ID: O20061113000232 |
News Archive
A new study published in the Journal of Biological Chemistry has revealed that drug Remdesivir could be useful in treating the deadly COVID-19 or the novel coronavirus that is infecting tens of thousands of people across the world.
Scientists have confirmed that prions, the mysterious proteins thought to cause chronic wasting disease (CWD) in deer, latch on tightly to certain minerals in soil and remain infectious.
With diabetes affecting the lives of millions of people throughout the Midwest, Meijer announced plans today to begin offering Metformin Immediate Release, the most commonly prescribed treatment for type 2 diabetes, at no cost to those with a medical prescription. Meijer's program will include doses prescribed in 500mg, 850mg and 1000mg tablets.
USHIFU, LLC (US HIFU), a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies and manufacturer of the Sonablate® 500 (Sonablate) medical device, announces the acquisition of certain Misonix HIFU assets and European distribution rights. In addition, through its transaction with Misonix, US HIFU acquires the Sonatherm® 600 medical device, a laparoscopic HIFU system used to ablate certain soft tissues.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Patrick Murphy, MD 2623 Shadelands Dr Ste 1, Walnut Creek, CA 94598-2512 Ph: (925) 933-8462 | Michael Patrick Murphy, MD 2623 Shadelands Dr Ste 1, Walnut Creek, CA 94598-2512 Ph: (925) 933-8462 |
News Archive
A new study published in the Journal of Biological Chemistry has revealed that drug Remdesivir could be useful in treating the deadly COVID-19 or the novel coronavirus that is infecting tens of thousands of people across the world.
Scientists have confirmed that prions, the mysterious proteins thought to cause chronic wasting disease (CWD) in deer, latch on tightly to certain minerals in soil and remain infectious.
With diabetes affecting the lives of millions of people throughout the Midwest, Meijer announced plans today to begin offering Metformin Immediate Release, the most commonly prescribed treatment for type 2 diabetes, at no cost to those with a medical prescription. Meijer's program will include doses prescribed in 500mg, 850mg and 1000mg tablets.
USHIFU, LLC (US HIFU), a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies and manufacturer of the Sonablate® 500 (Sonablate) medical device, announces the acquisition of certain Misonix HIFU assets and European distribution rights. In addition, through its transaction with Misonix, US HIFU acquires the Sonatherm® 600 medical device, a laparoscopic HIFU system used to ablate certain soft tissues.
› Verified 2 days ago
Glenn D. Schneider, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-4000 | |
Bryan Philip Fong, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-4000 | |
Dr. Rahul Seth, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 355 Lennon Ln Ste 235, Walnut Creek, CA 94598 Phone: 925-357-9050 Fax: 925-357-9040 | |
Nicole Daamen, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-4000 | |
Erica Christine Bennett, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 106 La Casa Via Ste 100, Walnut Creek, CA 94598 Phone: 925-239-2900 | |
Dr. Sarah Syed Connell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-4100 Fax: 925-295-5414 | |
Cornelius J.a. Jansen, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-4000 |